Prot #BTTC09-01: NU 12C02:A Phase I-II trial Everolimus and Sorafenib in Patients with Recurrent High-Grade Gliomas

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/7/13 → 1/7/23

Funding

  • University of Texas M. D. Anderson Cancer Center (Prot #BTTC09-01 // Prot #BTTC09-01)
  • Bayer HealthCare Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation (Prot #BTTC09-01 // Prot #BTTC09-01)